Why Patients Are Making The Switch: Stock & Supply Reliability
Switching to Wegovy from Mounjaro: UK Stock Availability Advantage
The primary reason patients consider switching to Wegovy from Mounjaro often centres on consistent supply availability. Unlike previous years when Wegovy faced significant stock shortages, our direct partnership with Novo Nordisk ensures reliable access to all doses throughout 2026. EverydayMeds maintains strategic inventory levels across the complete dose range - from 0.25mg starter pens to 2.4mg maintenance doses.
When switching to Wegovy from Mounjaro, patients benefit from Novo Nordisk's established UK manufacturing and distribution network. This translates to predictable restocking cycles and reduced risk of treatment interruptions. Our pharmacy (GPhC #9012878) processes orders within 24 hours of prescription approval, with temperature-controlled delivery ensuring medication integrity from our facility to your door.
Wegovy Pricing Structure for Mounjaro Switchers
Patients switching to Wegovy from Mounjaro will find competitive pricing across our complete dose range. The starter 0.25mg dose costs £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. New customers can apply discount code FIRST40 at checkout, while returning patients use code DOSE25 to access these final pricing levels.
Our Getting Started bundles offer particular value for those transitioning between treatments. The Intro Duo (0.25mg & 0.5mg) provides your first 8 weeks for £169.99, while the Progress Trio (0.5mg, 1mg & 1.7mg) covers weeks 5-16 at £369.99. These bundles ensure uninterrupted treatment progression without multiple ordering requirements, addressing a common concern when switching to Wegovy from Mounjaro.
Clinical Evidence Supporting the Switch to Wegovy
The STEP clinical trial programme provides robust evidence for patients considering switching to Wegovy from Mounjaro. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The STEP 5 extension demonstrated sustained clinically studied weight loss at 2 years, indicating long-term efficacy.
Recent SELECT cardiovascular outcomes data shows Wegovy may reduce major cardiovascular events by 20% in eligible patients. While both Wegovy and Mounjaro demonstrate efficacy in clinical trials, their different mechanisms mean individual responses can vary. This prescription-only medicine requires careful clinical assessment to determine suitability for your specific circumstances.
How Wegovy Works Differently from Mounjaro
Understanding the mechanism difference is crucial when switching to Wegovy from Mounjaro. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone. This works primarily on brain appetite centres to reduce hunger signals and promote feelings of fullness after smaller meals. The medication may also slow gastric emptying, contributing to prolonged satiety between meals. Unlike Mounjaro's dual GIP and GLP-1 action, Wegovy focuses specifically on GLP-1 pathways, which some patients find more suitable for their physiology. Both medications must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Streamlined Ordering Process for Treatment Switchers
Switching to Wegovy from Mounjaro through EverydayMeds involves a straightforward 3-step process designed for treatment continuity. Begin with our 3-minute online clinical assessment, covering your medical history, current medications, and treatment goals. Our registered prescribers review applications within 3 working days (express 24-hour service available), ensuring thorough evaluation before approval. Once prescribed, your Wegovy pens are dispatched via next-day delivery using our temperature-controlled cold-chain system. All packaging is discreet, and our delivery partners are trained in pharmaceutical handling requirements. Track your order through our patient portal, with SMS notifications at each stage from prescription approval to doorstep delivery.
Storage and Practical Advantages of Wegovy
A key practical benefit when switching to Wegovy from Mounjaro lies in storage flexibility. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day limit. This makes Wegovy more suitable for frequent travellers or those with limited fridge space. The FlexTouch pen design offers precise dose delivery with a clear dosing window to confirm injection completion. Wegovy follows a structured dose escalation: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, then 2.4mg for maintenance from week 17 onwards.
Supply Chain Reliability: Why Stock Matters When Switching
Treatment continuity becomes paramount when switching to Wegovy from Mounjaro, making reliable stock availability essential. Our partnership with Novo Nordisk provides advance visibility of manufacturing schedules and shipment timings. This allows strategic inventory planning to prevent the stock shortages that previously affected Wegovy availability in 2022-2023.
EverydayMeds operates a just-in-time inventory system balanced with safety stock levels across all five doses. Our warehouse maintains temperature-controlled storage meeting MHRA pharmaceutical standards, with automated stock rotation ensuring optimal product shelf life. When you're switching to Wegovy from Mounjaro, this infrastructure means predictable access without treatment gaps that could compromise your weight management progress.
Making the Switch: Order Your Wegovy Supply Today
Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which treatment best suits your individual needs. Ready to begin switching to Wegovy from Mounjaro? Complete your clinical assessment today using discount code FIRST40 (new customers) or DOSE25 (returning customers) applied at checkout. Our GPhC-registered pharmacy (#9012878) ensures pharmaceutical-grade handling from prescription to delivery. Visit https://everydaymeds.co.uk/collections/wegovy to start your assessment, with most applications processed within 24-72 hours. Take advantage of our reliable UK stock levels and begin your Wegovy journey this week, supported by our clinical team throughout your treatment transition.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
